• Latest Posts

Ginkgo Bioworks boosts gene therapy capacity with StrideBio asset acquisition

Ginkgo Bioworks launches Ginkgo Enzyme Services

Ginkgo Bioworks acquires Altar and Circularis

Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M

Delayed IPOs and Market Drops Batter Biotech Stocks

Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A


What are the Best Countries to Recruit Biotech Talents in 2017?

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

€41M for a Rising Star of Synthetic Biology: Ginkgo Bioworks